Mac-2 Binding Protein Glycosylation Isomer for Screening High-Risk Esophageal Varices in Liver Cirrhotic Patient
Authors:
- Saut Horas H. NababanSNSaut Horas H. Nababan
- Kemal Fariz KalistaKKKemal Fariz Kalista
- Chyntia O.M. JasirwanCJChyntia O.M. Jasirwan
- Juferdy KurniawanJKJuferdy Kurniawan
- Cosmas Rinaldi A. LesmanaCLCosmas Rinaldi A. Lesmana
- Andri S. SulaimanASAndri S. Sulaiman
- Irsan HasanIHIrsan Hasan
- Rino A. GaniRGRino A. Gani
Open Access
Abstract
Background: Esophageal varices occur at middle to advanced stages of cirrhosis and are associated with increased mortality due to their potential for rupture and bleeding. The aim of this study is to examine the accuracy of a surrogate marker, Mac-2 binding protein glycosylation isomer (M2BPGi), for screening high-risk esophageal varices in cirrhotic patients. Methods: Ninety-four cirrhotic patients who underwent endoscopy screening at Cipto Mangunkusumo Hospital, Jakarta, Indonesia were included. Patients with a history of ligation, portal vein thrombosis, or hepatocellular carcinoma were excluded. All enrolled patients underwent ultrasonography, transient elastography, and laboratory tests. The HISCL-5000 Sysmex analyzer was used to measure M2BPGi levels. Results: Of these 94 patients, 27 had high-risk esophageal varices and 67 had non-high-risk esophageal varices. M2BPGi levels were higher in patients with high-risk esophageal varices compared with those with non-high-risk esophageal varices (cutoff index (COI) of 11.4 vs. 3.7, p < 0.001). The sensitivity, specificity, positive predictive value, and negative predictive value of M2BPGi with a cutoff value of 5 COI was 92.6%, 70.1%, 55.6%, and 95.9%, respectively. Conclusions: M2BPGi could be used as a non-invasive surrogate marker for ruling out high-risk esophageal varices in cirrhotic patients. This method is cheap and non-invasive and could be used as a screening tool in resource-limited settings.Keywords
Funding Information
- Sysmex Indonesia (HK.03.01/VII.3/35278/2019; 113/AOI/FK/UI/2019)
This publication has 25 references indexed in Scilit:
- Diagnostic accuracy of liver and spleen stiffness measured by fibroscan® in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antiviralsGastroenterología y Hepatología, 2021
- Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver DiseasesAnnals of Laboratory Medicine, 2021
- Managing liver cirrhotic complications: Overview of esophageal and gastric varicesClinical and Molecular Hepatology, 2020
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Gastroenterology & Hepatology, 2020
- Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver DiseaseClinical Gastroenterology and Hepatology, 2018
- Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center StudyRadiology, 2017
- Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal HemorrhageJournal of Clinical Gastroenterology, 2017
- Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver CirrhosisMedicine, 2015
- The Cost of Screening Esophageal VaricesJournal of Computer Assisted Tomography, 2014
- Transient elastography: Applications and limitationsHepatology Research, 2008